Alfred22
New member
They investigate irregularities in the purchase of oncological drugs in the management of Alberto Fernández for more than $65 billion - Infobae
Source:
Investigan irregularidades en la compra de medicamentos oncológicos en la gestión de Alberto Fernández por más de $65 mil millones
La información llegó ayer al juzgado de Julián Ercolini. La denuncia la realizó el Ministerio de Capital Humano a cargo de Sandra Pettovello. “Se realizaban negocios imperdonables a expensas de los más necesitados”, sostiene el escrito
www.infobae.com
March 07, 2024
The information arrived yesterday at Julián Ercolini's court. The complaint was made by the Ministry of Human Capital led by Sandra Pettovello. “Unforgivable businesses were carried out at the expense of those most in need,” the document maintains.
By Andres Klipphan
They denounce the irregular purchase of medicines during the government of Alberto Fernández
The federal court of Julián Ercolini investigates alleged irregularities in the purchase of high-cost medications , such as oncology and HIV-AIDS, during the administration of Alberto Fernández for $65,289,274,180 .
The complaint was made by the Minister of Human Capital, Sandra Pettovello , after an internal audit revealed a lack of controls in the purchase of “very expensive medications” that made it possible to acquire these supplies at surcharges through “ directed purchases” , a whimsical selection. of suppliers and informal budgets.
The operations were carried out through the Directorate of Direct Assistance for Special Situations (DADSE). An area that, by Fernández's decision, was transferred from the then Ministry of Health to the former Social Development portfolio.
The Minister of Human Capital denounced the irregular purchase of oncological medications for more than 65 billion pesos (Gustavo Gavotti)
The judicial document, dated at the beginning of February and published by Infobae , highlights that through these maneuvers " unforgivable businesses were carried out at the expense of those most in need and for extremely sensitive issues ", for people without coverage and in highly vulnerable situations. and that they processed subsidies for the acquisition of drugs with high economic impact such as immunosuppressive medications, oncological medications, for diseases of the immune system, atrial fibrillation, among others, as well as prostheses for operations such as hips.
The Human Capital audit also questions the transfer of the DADSE from Health to Social Development, which during Fernández's administration was headed by Daniel Arroyo , Juan Zavaleta and Victoria Tolosa Paz . For this reason, Pettovello decided to modify the structure of his portfolio, which absorbed the ministries of Labor, Education, the Ministry of Women, Gender and Diversity and Social Development.
Through Administrative Decision 76/2024, Pettovello transferred his portfolio from DADSE to the Ministry of Health, “from where he should never have left ,” according to the La Libertad Avanza official.
Yesterday morning, Leila Daniela Gianni , legal undersecretary of the Ministry of Human Capital, presented to Ercolini the list of all the subsidies granted by the DADSE between May 21, 2020 to December 6, 2023 at the request of the magistrate, as as this medium advanced.
The complaint of Capital Humano before federal judge Julián Ercolini (Source)
There are 33,008 payment allocations ranging from $78,000 to more than $34,000,000 each. In 2020, subsidies were managed and granted for the purchase of this type of medicines for $1,582,388,462. In 2021 the figure rose to $7,609,569,424. While for the year 2022 they were $17,024,535,217 and in 2023 the subsidies granted reached a value of $39,072,781,075. In total they were $65,289,274,180 .
The million-dollar purchases investigated for alleged irregularities circulated through less than 30 laboratories, pharmacies, drugstores and hospital suppliers.
In one of the most salient paragraphs, the document presented by Pettovello's ministry describes: “The selection of DADSE suppliers for the purposes of the Argentine State acquiring medicines for billions of pesos was carried out via e-mails ( simple and common emails, not encrypted, without closed envelope or security) to a chain of users that was not periodically updated nor was its ownership certified. Once these emails were received, certain supposed suppliers sent informal quotes without signature or any rigor.”
Judge Julián Ercolini investigates alleged irregularities in the purchase of medicines by the DADSE during the administration of Alberto Fernández (Adrián Escandar)
The alleged mismanagement and lack of controls in the DADSE had already been warned twice by the Internal Audit Unit (UAI), in 2019 and 2022. However, the authorities did not modify the purchasing system. Among the suppliers that would have been favored would be companies that are “rubber stamps” and even pharmaceutical groups, public limited companies and unknown companies without any type of background in the pharmacological or medical industry. Infobae has the names that appear on a numbered Excel spreadsheet, but the names are reserved, since they are under investigation.
The criminal complaint describes that the process to access medications and other high-value supplies began “with sending an email to a contact list” from the email address urgentdadse@desarrollosocial.gob.ar .
Once these e-mails were received, the letter continues, “ certain supposed suppliers send informal estimates without any signature or rigor and, by virtue of such estimates, the supplier from whom the very expensive medications were purchased was randomly selected , without even a table.” comparative as required by the regulations” provided by the General Sindicature of the Nation (SIGEN) by which the entire National Public Administration (APN) is governed.
The Human Capital document that Ercolini is investigating investigates the alleged crimes of “ fraud against the public administration, abuse of authority and violation and non-compliance with the duties of a public official .”
In court, the Human Capital portfolio assured that “ the patients who receive the supplies are not the reason for the complaint and will continue to keep their medications .”
